UCP2 and breast carcinoma: More interestingly, it was observed that the expression of UCP-2 was increased in MCF-7/Dox at both protein and mRNA levels (Fig 1C), which indicates that miR133a/UCP-2 might be involved in the development of Doxorubicin resistance in breast cancer cell line MCF-7.